Cipher Pharmaceuticals Inc Share Price Nasdaq
Equities
CA17253X1050
Pharmaceuticals
Sales 2024 * | 3.01Cr 2.21Cr 184.36Cr | Sales 2025 * | 2.94Cr 2.16Cr 179.81Cr | Capitalization | 21Cr 15Cr 1.28TCr |
---|---|---|---|---|---|
Net income 2024 * | 1.8Cr 1.32Cr 110.08Cr | Net income 2025 * | 1.6Cr 1.17Cr 98Cr | EV / Sales 2024 * | 6.95 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 7.13 x |
P/E ratio 2024 * |
11.7
x | P/E ratio 2025 * |
13.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.49% |
Latest transcript on Cipher Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Craig Mull
CEO | Chief Executive Officer | - | 26/19/26 |
Bryan Jacobs
DFI | Director of Finance/CFO | - | 15/22/15 |
James Bowen
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harold Wolkin
BRD | Director/Board Member | 72 | 08/16/08 |
Douglas N. Deeth
BRD | Director/Board Member | 76 | 21/23/21 |
Craig Mull
CEO | Chief Executive Officer | - | 26/19/26 |
1st Jan change | Capi. | |
---|---|---|
+32.09% | 69TCr | |
+29.39% | 58TCr | |
-1.34% | 37TCr | |
+20.34% | 33TCr | |
+7.39% | 29TCr | |
+14.25% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+8.49% | 17TCr |